Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Stem Cell Research & Therapy|January 9, 2021
Persistence of intramyocardially transplanted murine induced pluripotent stem cell-derived cardiomyocytes from different developmental stagesGabriel Peinkofer, Martina Maass, Kurt Pfannkuche, et al.Cardiovascular Therapeutics|October 16, 2010
Cardiac cell therapies: the next generationYeong-Hoon Choi, Tomo Saric, Boris Nasseri, et al.Biotechniques|April 3, 2010
A Cre-based double fluorescence indicator system for monitoring cell fusion events and selection of fused cellsKurt Pfannkuche, Dimitry Spitkovsky, Frank Thomas Wunderlich, et al.Journal of Electrocardiology|September 16, 2008
Biological pacemakers: characterization in an in vitro coculture modelTobias Hannes, Marcel Halbach, Rewa Nazzal, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2007
Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTLZeinab Abdullah, Tomo Saric, Hamid Kashkar, et al.Nature Immunology|November 19, 2002
An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptidesTomo Saric, Shih-Chung Chang, Akira Hattori, et al.Nature Immunology|November 19, 2002
The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residuesIan A York, Shih-Chung Chang, Tomo Saric, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 2009
Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitroAlexey Kuzmenkin, Huamin Liang, Guoxing Xu, et al.Cancer Immunology, Immunotherapy : CII|July 4, 2021
Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumorsHamid Khodayari, Saeed Khodayari, Elmira Ebrahimi, et al.Immunity|March 22, 2003
The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentationIan A York, Annie X Y Mo, Kristen Lemerise, et al.Pageof 4